Facioscapulohumeral Muscular Dystrophy Type 2 clinical trials

Explore recruiting facioscapulohumeral muscular dystrophy type 2 clinical trials.

Recruiting facioscapulohumeral muscular dystrophy type 2 studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Facioscapulohumeral Muscular Dystrophy Type 2 trials by city

Facioscapulohumeral Muscular Dystrophy Type 2 in Toronto Facioscapulohumeral Muscular Dystrophy Type 2 in Vancouver Facioscapulohumeral Muscular Dystrophy Type 2 in Montreal Facioscapulohumeral Muscular Dystrophy Type 2 in Calgary Facioscapulohumeral Muscular Dystrophy Type 2 in Edmonton Facioscapulohumeral Muscular Dystrophy Type 2 in Ottawa Facioscapulohumeral Muscular Dystrophy Type 2 in Winnipeg Facioscapulohumeral Muscular Dystrophy Type 2 in Quebec City Facioscapulohumeral Muscular Dystrophy Type 2 in Hamilton Facioscapulohumeral Muscular Dystrophy Type 2 in Kitchener Facioscapulohumeral Muscular Dystrophy Type 2 in London Facioscapulohumeral Muscular Dystrophy Type 2 in Halifax Facioscapulohumeral Muscular Dystrophy Type 2 in New York Facioscapulohumeral Muscular Dystrophy Type 2 in Los Angeles Facioscapulohumeral Muscular Dystrophy Type 2 in Chicago Facioscapulohumeral Muscular Dystrophy Type 2 in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease